---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-037681"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T15:33:01.206346+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Eterna Therapeutics posts August 2023 investor presentation; no material news disclosed

## Summary
- Item 7.01 furnished new investor presentation (Exhibit 99.1) with no specific financial results or corporate events.
- Presentation available on company website; filing does not contain earnings, guidance, or operational updates.
- No material changes, transactions, or forward-looking statements identified in the furnished exhibit.
- Routine disclosure intended to update investor materials without new material information.

## SEC filing metadata
- accession: 0001140361-23-037681
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036123037681/0001140361-23-037681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036123037681/brhc20056925_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-037681
- JSON: https://secwatch.observer/filing/0001140361-23-037681.json
- Plain text: https://secwatch.observer/filing/0001140361-23-037681.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.